PRJNA804958
The Whole Exon Sequencing (WES) Data of CD19/CD22 Cocktail CAR T-Cell Immunotherapy in Diffuse Large B-cell Lymphoma Patients.
In the present study, a total of 48 patients patients of DLBCL treated with murine CD19/CD22 cocktail CAR T-therapy were included in the research and divided into two groups (a T-normal group [n=22] and a T-defect [n=26] group.